Sarah Mak

Sarah is an Approach-specific Scientist of ORI Capital. Sarah’s primary responsibilities include updating the in-house science and technology platform as well as certain post investment portfolio activities. Prior to joining ORI Capital, Sarah worked as a Post-doctoral Fellow in the Department of Medicine, HKU, investigating the pathology of chronic kidney diseases. In Sarah’s academic career, she focused on endocrinology and neuroscience. Sarah received a BSc in Biotechnology and Microbiology and a PhD from the University of Hong Kong.